Nghiên cứu vai trò của osteopontin-1 trong các dòng tế bào ung thư nội mạc tử cung

Bakkum-Gamez JN, Gonzales-Bosquet J, Laack NN et al (2008) Current issues in the management of endometrial cancer. Mayo Clin Proc 83:97–112 Bottke D, Wiegel T, Kreienberg R et al (2007) Stage IB endometrial cancer. Does lymphadenectomy replace adjuvant radiotherapy? Strahlenther Onkol 183:600–604 Chang SH, Minai-Tehrani A, Shin JY et al (2012) Beclin1-induced autophagy abrogates radioresistance of lung cancer cells by suppressing osteopontin. J Radiat Res 53:422–432 Djuzenova C, Mühl B, Schakowski R et al (2004) Normal expression of DNA repair proteins, hMre11, Rad50 and Rad51 but protracted formation of Rad50 containing foci in X-irradiated skin fibroblasts from radiosensitive cancer patients. Br J Cancer 90:2356–2363 Du XL, Jiang T, Sheng XG et al (2009) Inhibition of osteopontin suppresses in vitro and in vivo angiogenesis in endometrial cancer. Gynecol Oncol 115:371–376 Erpolat OP, Gocun PU, Akmansu M et al (2013) Hypoxia-related molecules HIF-1α, CA9, and osteopontin. Strahlenther Onkol 189:147–154 Fisher LW, Fedarko NS (2003) Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins. Connect Tissue Res 44:33–40 Hänsgen G, Nagel M, Dunst J, Enke H (1999) Postoperative radiotherapy in endometrial carcinoma. A retrospective analysis of 541 cases. Strahlenther Onkol 175:548–553 Herbolsheimer M (1997) Radical lymph node excision in endometrial carcinoma: the restriction of pelvic irradiation to node-positive cases? Strahlenther Onkol 173:288–289 Hille A, Christiansen H, Pradier O et al (2005) Effect of pentoxifylline and tocopherol on radiation proctitis/enteritis. Strahlenther Onkol 181:606–614 Huguenin P, Baumert B, Lütolf UM et al (1999) Curative radiotherapy in elderly patients with endometrial cancer. Patterns of relapse, toxicity and quality of life. Strahlenther Onkol 175:309–314 Karadag A, Ogbureke KUE, Fedarko NS, Fisher LW (2004) Bone sialoprotein, matrix metalloproteinase 2, and αvβ3 integrin in osteotropic cancer cell invasion. J Natl Cancer Inst 96:956–965 Lin YH, Yang-Yen HF (2001) The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3-kinase/Akt signaling pathway. J Biol Chem 276:46024–46030 Makrydimas G, Zagorianakou N, Zagorianakou P, Agnantis NJ (2003) CD44 family and gynaecological cancer. In Vivo 17:633–640 Micke O, Bruns F, Halek G et al (2003) Long-term results of postoperative radiotherapy for stage I endometrial carcinoma. Strahlenther Onkol 179:729–736 Pötter R, Knocke TH (1998) Isolated vaginal recurrences in endometrial carcinoma: treatment results using high-dose-rate intracavitary brachytherapy and external beam radiotherapy. Strahlenther Onkol 174:488–489 Polat B, Wohlleben G, Katzer A et al (2013) Influence of osteopontin silencing on survival and migration of lung cancer cells. Strahlenther Onkol 189:62–67 Rae JM, Creighton CJ, Meck JM et al (2007) MDA-MB-435 cells are derived from M14 melanoma cells-a loss for breast cancer, but a boon for melanoma research. Breast Cancer Res Treat 104:13–19 Renner W, Atzinger A (1997) Value of adjuvant progestagen therapy in patients with endometrial carcinoma. Strahlenther Onkol 173:485–486 Rittling SR, Chambers AF (2004) Role of osteopontin in tumor progression. Br J Cancer 80:1877–1881 Salih E, Ashkar S, Gerstenfeld LC, Glimcher MJ (1997) Identification of the phosphorylated sites of metabolically 32P-labeled osteopontin from cultured chicken osteoblasts. J Biol Chem 272:13966–13973 Senger DR, Perruzzi CA, Gracey CF et al (1988) Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation. Cancer Res 48:5770–5774 Senger DR, Perruzzi CA, Papadopoulus-Sergiou A, Water L van de (1994) Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain. Mol Biol Cell 5:565–574 Shevde LA, Das S, Clark DW, Samant RS (2010) Osteopontin: an effector and an effect of tumor metastasis. Curr Mol Med 10:71–81 Shevde LA, Samant RS, Paik JC et al (2006) Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma MDA-MB-435. Clin Exp Metastasis 23:123–133 Solberg TD, Nearman J, Mullins J et al (2008) Correlation between tumor growth delay and expression of cancer and host VEGF, VEGFR2, and osteopontin in response to radiotherapy. Int J Radiat Oncol Biol Phys 72:918–926 Toy H, Yavas O, Eren O et al (2009) Correlation between osteopontin protein expression and histological grade of astrocytomas. Pathol Oncol Res 15:203–207 Weber GF (2001) The metastatic gene osteopontin: a candidate target for cancer therapy. Biochim Biophys Acta 1552:61–85 Weber GF, Ashkar S, Glimcher MJ, Cantor H (1996) Receptor ligand interaction between DC44 and osteopontin (Eta-1). Science 271:509–512 Weitmann HD, Knocke TH, Waldhäusl C, Pötter R (2006) Ultrasound-guided interstitial brachytherapy in the treatment of advanced vaginal recurrences from cervical and endometrial carcinoma. Strahlenther Onkol 182:86–95 Zhang A, Liu Y, Shen Y et al (2010) Osteopontin silencing by small interfering RNA induces apoptosis and suppresses invasion in human renal carcinoma Caki-1 cell. Med Oncol 27:1179–1184 Zang LL, Shao SL, Wu Y (2010) Expression of osteopontin and B7-H4 in epithelial ovarian neoplasm and their significance. Chin J Cancer 29:25–29 Zohar R, Zhu B, Liu P et al (2004) Increased cell death in osteopontin-deficient cardiac fibroblasts occurs by a caspase-3-independent pathway. Am J Physiol Heart Circ Physiol 287:H1730–H1739